From awareness to adoption: Why strategic PR is a growth engine for health tech

By Published On: August 19, 2025Last Updated: September 5, 2025
From awareness to adoption: Why strategic PR is a growth engine for health tech

By EatMoreFruit Communications

Many health tech and medical device firms spend years refining technology, securing CE marks and FDA approvals, only to stumble at market launch.

The missing link? Strategic PR that drives stakeholders from passive awareness to active adoption.

The Adoption Funnel in Numbers

According to Deloitte’s 2025 Global MedTech Survey, 61 per cent of new devices fail to meet first-year revenue targets, often because they underestimate the communication needed post-approval.

Meanwhile, launches underpinned by robust PR and KOL programs were 2.4x more likely to achieve market-share goals.

Furthermore, Bain’s recent medtech sector analysis shows brands with higher market mindshare and clinician endorsement achieved exit multiples up to 25 per cent above peers, underscoring PR’s impact on long-term value.

Beyond Media Coverage

Healthcare PR today is a multi-pronged growth lever. At EatMoreFruit, we design programmes that:

  • Deploy thought leadership to position clinicians as champions of innovation
  • Activate patient narratives that humanise clinical results
  • Use targeted trade and regional media to engage local procurement influencers

Case in Point: For SilverCloud Health, the UK’s leading digital mental health provider, we helped design and deliver their flagship Digital Mindset Conference — a hybrid event that brought together NHS Trust leaders, commissioners, health insurers, and policymakers to tackle the post-pandemic mental health crisis.

With a keynote from Alastair Campbell and contributions from the CEOs of leading NHS organisations, the event blended thought leadership, stakeholder engagement, and rich content.

The result? More customer meetings than any other SilverCloud marketing initiative that year — and a PR-led campaign that turned conversation into commercial traction.

“Without sustained communication, even best-in-class technologies can fail. Effective PR doesn’t just generate headlines,” says Paul Jarman, CEO of EatMoreFruit.

“It creates a structured path that builds clinician understanding, trust and eventually preference.”

At EatMoreFruit, we build PR programmes that do more than generate a buzz — we help medtech brands influence decision-makers, accelerate market entry, and drive measurable outcomes.

Visit eatmorefruit.health or contact us today.

McDermott advises Oaktree On $125m term loan facility to Oxford Biomedica
The sleep app on a mission to improve public health